Ben Wolf is quoted on practical considerations for manufacturers in light of the Food and Drug Administration’s post-pandemic medical device transition plan.
In the News
February 17, 2022
Medtech Insight | Still Mulling EUA Transition Options? Don’t Wait too Long, Attorney Says
Media Contact